Literature DB >> 2706256

Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper.

L R McLean1, K A Hagaman.   

Abstract

Human plasma low-density lipoproteins (LDL) were incubated with 10 microM probucol for 1 h at 37 degrees C. Probucol incorporation into the LDL was complete as judged by filtration through a 0.2-micron filter, ultracentrifugation, and gel filtration. LDL with and without probucol were incubated for up to 24 h with 5 microM Cu2+ at 37 degrees C. Copper oxidation increased the content of random structure in the LDL protein from 30% to 36% at the expense of beta-structure (which decreased from 22% to 16%) without a change in alpha-helical content as measured by circular dichroism spectroscopy. This loss of beta-structure was prevented by the presence of probucol in the LDL during the copper incubation. Probucol reduced the rate of increase of fluorescence during copper oxidation at 37 degrees C. After 6 h, the fluorescence intensity at 360-nm excitation and 430-nm emission was 30% less in probucol-containing samples. Probucol had no effect on the circular dichroic spectrum of LDL and only minimal effects (less than 5%) on the fluorescence emission spectrum at wavelengths below 500 nm. Two fluorescence peaks, with emission at 420 nm and excitation at 340 and 360 nm, are resolved in three-dimensional fluorescence spectra of oxidized LDL. Probucol reduces the intensity of both peaks equally. The binding of a highly reactive heparin (HRH) fraction to LDL was measured by titration of LDL with HRH in the presence of fluoresceinamine-labeled HRH. The decrease in fluorescence anisotropy of the labeled HRH is proportional to the concentration of bound HRH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706256     DOI: 10.1021/bi00427a043

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Nicanartine improves in vitro resistance of lipoproteins to oxidation.

Authors:  E Dailly; S Urien; P Wülfroth; J P Tillement
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

2.  Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.

Authors:  A Daugherty; B S Zweifel; G Schonfeld
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.

Authors:  L Iuliano; A R Colavita; C Camastra; V Bello; C Quintarelli; M Alessandroni; F Piovella; F Violi
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 4.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids.

Authors:  L R McLean; K A Hagaman; W S Davidson
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

6.  Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.

Authors:  Q Chen; H Esterbauer; G Jürgens
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions.

Authors:  C Smith; M J Mitchinson; O I Aruoma; B Halliwell
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

8.  Cholesterol interaction with recombinant human sterol carrier protein-2.

Authors:  S M Colles; J K Woodford; D Moncecchi; S C Myers-Payne; L R McLean; J T Billheimer; F Schroeder
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

9.  The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.

Authors:  A Daugherty; B S Zweifel; G Schonfeld
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

10.  Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.

Authors:  D F Meyer; M O Mayans; P H Groot; K E Suckling; K R Bruckdorfer; S J Perkins
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.